<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Krol E</submitter><funding>Ministry of Science and Higher Education, Poland</funding><pagination>E1700</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5578090</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(8)</volume><pubmed_abstract>Influenza virus infection is a major cause of morbidity and mortality worldwide. Due to the limited ability of currently available treatments, there is an urgent need for new anti-influenza drugs with broad spectrum protection. We have previously shown that two 2-deoxy sugar derivatives of uridine (designated IW3 and IW7) targeting the glycan processing steps during maturation of viral glycoproteins show good anti-influenza virus activity and may be a promising alternative approach for the development of new anti-influenza therapy. In this study, a number of IW3 and IW7 analogues with different structural modifications in 2-deoxy sugar or uridine parts were synthesized and evaluated for their ability to inhibit influenza A virus infection in vitro. Using the cytopathic effect (CPE) inhibit</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.</pubmed_title><pmcid>PMC5578090</pmcid><funding_grant_id>IP2011 027271</funding_grant_id><pubmed_authors>Krejmer-Rabalska M</pubmed_authors><pubmed_authors>Wandzik I</pubmed_authors><pubmed_authors>Krol E</pubmed_authors><pubmed_authors>Szewczyk B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.</name><description>Influenza virus infection is a major cause of morbidity and mortality worldwide. Due to the limited ability of currently available treatments, there is an urgent need for new anti-influenza drugs with broad spectrum protection. We have previously shown that two 2-deoxy sugar derivatives of uridine (designated IW3 and IW7) targeting the glycan processing steps during maturation of viral glycoproteins show good anti-influenza virus activity and may be a promising alternative approach for the development of new anti-influenza therapy. In this study, a number of IW3 and IW7 analogues with different structural modifications in 2-deoxy sugar or uridine parts were synthesized and evaluated for their ability to inhibit influenza A virus infection in vitro. Using the cytopathic effect (CPE) inhibit</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2026-07-15T18:30:29.542Z</modification><creation>2019-03-27T02:55:01Z</creation></dates><accession>S-EPMC5578090</accession><cross_references><pubmed>28777309</pubmed><doi>10.3390/ijms18081700</doi></cross_references></HashMap>